Medicus Pharma (MDCX) Return on Assets (2025 - 2026)
Medicus Pharma's (MDCX) quarterly Return on Assets came in at 0.02% in Q4 2025, down 39.35% on a QoQ basis from 0.01% in Q3 2025.
Medicus Pharma (MDCX) Return on Assets (2025 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 1 years of Return on Assets data on file, last reported at 0.02% in Q4 2025.
- Quarterly Return on Assets changed N/A year-over-year to 0.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02% (changed N/A YoY) and the FY2025 annual result came in at 0.06%, down 1.0% from the prior year.
- Return on Assets slipped to 0.02% in Q4 2025, from 0.01% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2025 to a low of 0.03% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.00% |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.00% |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.00% |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.00% |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.00% |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.00% |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.00% |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 0.00% |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.01% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.03% |